West Lothian, United Kingdom

Janet Anne Halliday

This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Ferring B.v., Controlled Therapeutics (Scotland) Ltd.. Active years: 2002-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Janet Anne Halliday. Retrieved from https://idiyas.com/inventor/janet-anne-halliday

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 129(Granted Patents)


Location History:

  • Bo'ness, GB (2002)
  • West Lothian, GB (2013 - 2018)

Company Filing History:


Years Active: 2002-2018

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Janet Anne Halliday

Introduction

Janet Anne Halliday, an inventive spirit from West Lothian, GB, has made significant contributions to the field of polymer science, particularly in developing hydrophilic polyurethane compositions. With a remarkable portfolio of 8 patents, Halliday stands out as a prominent figure in innovative materials for controlled release applications.

Latest Patents

Among her latest patents, Halliday has introduced groundbreaking hydrophilic polyurethane compositions. One patent explores a controlled-release composition that incorporates a water-swellable linear polymer with an active agent. This polymer is synthesized through the reaction of a polyethylene oxide (with a molecular weight of 4000 g/mol or less), an aliphatic diol, and a difunctional isocyanate, maintaining specific ratios to optimize performance. Additionally, she has developed water-swellable polymers that can achieve swelling percentages ranging from 20% to 1700%, showcasing versatility in applications such as controlled drug delivery systems.

Career Highlights

Janet Halliday has established her career primarily with Ferring B.V., where her innovative work on polymers has contributed to advancements in the pharmaceutical industry. Her expertise in creating polymers that effectively load and release pharmaceutically active agents has positioned her as a crucial asset to her organization and the wider scientific community.

Collaborations

Throughout her career, Halliday has collaborated with accomplished individuals such as Jukka Tuominen and Mark Alexander Livingstone. These partnerships have enriched her research and exemplified the importance of teamwork in driving innovation forward.

Conclusion

With a solid foundation of patents and a commitment to advancing polymer technology, Janet Anne Halliday exemplifies the essence of innovation. Her work not only contributes to the scientific community but also enhances the potential for pharmaceutical applications, ultimately improving health outcomes for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…